Well Lead Med Co Ltd (603309) — Cash Flow-to-Debt Ratio
Well Lead Med Co Ltd (603309) has a Cash Flow-to-Debt Ratio of 0.13x as of September 2025, meaning its operating cash flow of CN¥126.26 Million could theoretically repay 0% of its total liabilities (CN¥960.53 Million) in one year. See Well Lead Med Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Well Lead Med Co Ltd Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Well Lead Med Co Ltd across 14 annual periods. Also explore 603309 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Well Lead Med Co Ltd (2011–2024)
Year-by-year debt coverage analysis for Well Lead Med Co Ltd. For market capitalisation and broader financial context, see Well Lead Med Co Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.33x | CN¥306.26 Million | CN¥937.61 Million | ▲ +7.5% |
| 2023 | 0.30x | CN¥233.51 Million | CN¥768.37 Million | ▼ -50.0% |
| 2022 | 0.61x | CN¥391.13 Million | CN¥643.85 Million | ▲ +75.4% |
| 2021 | 0.35x | CN¥187.28 Million | CN¥540.87 Million | ▼ -47.7% |
| 2020 | 0.66x | CN¥228.44 Million | CN¥344.83 Million | ▲ +55.4% |
| 2019 | 0.43x | CN¥178.79 Million | CN¥419.35 Million | ▲ +125.0% |
| 2018 | 0.19x | CN¥89.89 Million | CN¥474.41 Million | ▼ -71.8% |
| 2017 | 0.67x | CN¥74.34 Million | CN¥110.63 Million | ▼ -13.9% |
| 2016 | 0.78x | CN¥85.35 Million | CN¥109.37 Million | ▼ -1.9% |
| 2015 | 0.80x | CN¥81.47 Million | CN¥102.43 Million | ▲ +15.3% |
| 2014 | 0.69x | CN¥107.34 Million | CN¥155.62 Million | ▲ +62.0% |
| 2013 | 0.43x | CN¥72.85 Million | CN¥171.15 Million | ▼ -18.3% |
| 2012 | 0.52x | CN¥83.23 Million | CN¥159.77 Million | ▲ +103.2% |
| 2011 | 0.26x | CN¥44.08 Million | CN¥171.89 Million | — |